A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Summary

The purpose of this study is to evaluate the effects of a drug known as CS-747 (also known as prasugrel) on subjects having a procedure called a percutaneous coronary intervention (also referred to as PCI) in which a doctor will attempt to open a blocked vessel (or vessels) in the heart using a catheter (a long thin tube) that has a small balloon on the end. In many cases, patients who have this procedure receive a stent, a small wire spring that helps keep the vessel open.

Timeline

Start

2003-04

Primary completion

2004-01

Completion

2004-01

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Clopidogrel vs Prasugrel (CS-747) Combined; p = 0.590; Log Rank NCT00059215 ↗

Drugs

Indications